IBEX TECHNOLOGIES INC (IBT.CA) Fundamental Analysis & Valuation

TSX-V:IBT • CA4489375085

1.44 CAD
0 (0%)
Last: Apr 5, 2024, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This IBT.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall IBT gets a fundamental rating of 6 out of 10. We evaluated IBT against 24 industry peers in the Biotechnology industry. IBT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. IBT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. IBT.CA Profitability Analysis

1.1 Basic Checks

  • IBT had positive earnings in the past year.
  • In the past year IBT had a positive cash flow from operations.
  • Of the past 5 years IBT 4 years were profitable.
  • IBT had a positive operating cash flow in 4 of the past 5 years.
IBT.CA Yearly Net Income VS EBIT VS OCF VS FCFIBT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M 2M 3M

1.2 Ratios

  • With an excellent Return On Assets value of 22.64%, IBT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • The Return On Equity of IBT (28.25%) is better than 100.00% of its industry peers.
  • The Return On Invested Capital of IBT (6.83%) is better than 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for IBT is below the industry average of 11.54%.
Industry RankSector Rank
ROA 22.64%
ROE 28.25%
ROIC 6.83%
ROA(3y)14.54%
ROA(5y)7.95%
ROE(3y)18.48%
ROE(5y)9.94%
ROIC(3y)9.26%
ROIC(5y)N/A
IBT.CA Yearly ROA, ROE, ROICIBT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

1.3 Margins

  • The Profit Margin of IBT (51.82%) is better than 100.00% of its industry peers.
  • IBT's Profit Margin has improved in the last couple of years.
  • IBT has a better Operating Margin (19.58%) than 100.00% of its industry peers.
  • IBT's Operating Margin has improved in the last couple of years.
  • IBT's Gross Margin of 71.29% is amongst the best of the industry. IBT outperforms 88.00% of its industry peers.
  • IBT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19.58%
PM (TTM) 51.82%
GM 71.29%
OM growth 3Y11.49%
OM growth 5YN/A
PM growth 3Y41.01%
PM growth 5YN/A
GM growth 3Y6.79%
GM growth 5Y12.72%
IBT.CA Yearly Profit, Operating, Gross MarginsIBT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. IBT.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IBT is still creating some value.
  • IBT has less shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, IBT has an improved debt to assets ratio.
IBT.CA Yearly Shares OutstandingIBT.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
IBT.CA Yearly Total Debt VS Total AssetsIBT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

  • An Altman-Z score of 4.22 indicates that IBT is not in any danger for bankruptcy at the moment.
  • IBT's Altman-Z score of 4.22 is amongst the best of the industry. IBT outperforms 92.00% of its industry peers.
  • The Debt to FCF ratio of IBT is 1.60, which is an excellent value as it means it would take IBT, only 1.60 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 1.60, IBT belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
  • IBT has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • IBT has a Debt to Equity ratio (0.10) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.6
Altman-Z 4.22
ROIC/WACC0.89
WACC7.68%
IBT.CA Yearly LT Debt VS Equity VS FCFIBT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

  • A Current Ratio of 5.08 indicates that IBT has no problem at all paying its short term obligations.
  • The Current ratio of IBT (5.08) is better than 76.00% of its industry peers.
  • A Quick Ratio of 4.97 indicates that IBT has no problem at all paying its short term obligations.
  • IBT has a Quick ratio of 4.97. This is in the better half of the industry: IBT outperforms 72.00% of its industry peers.
Industry RankSector Rank
Current Ratio 5.08
Quick Ratio 4.97
IBT.CA Yearly Current Assets VS Current LiabilitesIBT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. IBT.CA Growth Analysis

3.1 Past

  • IBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 139.95%, which is quite impressive.
  • IBT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 59.15% yearly.
  • IBT shows a decrease in Revenue. In the last year, the revenue decreased by -0.82%.
  • The Revenue has been growing by 9.64% on average over the past years. This is quite good.
EPS 1Y (TTM)139.95%
EPS 3Y59.15%
EPS 5YN/A
EPS Q2Q%20.09%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y12.87%
Revenue growth 5Y9.64%
Sales Q2Q%17.51%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IBT.CA Yearly Revenue VS EstimatesIBT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

Find the best growth stocksShow best growing peers

5

4. IBT.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.00, which indicates a very decent valuation of IBT.
  • IBT's Price/Earnings ratio is rather cheap when compared to the industry. IBT is cheaper than 100.00% of the companies in the same industry.
  • IBT is valuated cheaply when we compare the Price/Earnings ratio to 26.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9
Fwd PE N/A
IBT.CA Price Earnings VS Forward Price EarningsIBT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 96.00% of the companies in the same industry are more expensive than IBT, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBT indicates a rather cheap valuation: IBT is cheaper than 92.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 34.47
EV/EBITDA 14.11
IBT.CA Per share dataIBT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4 0.5

4.3 Compensation for Growth

  • The excellent profitability rating of IBT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IBT.CA Dividend Analysis

5.1 Amount

  • No dividends for IBT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

IBT.CA Fundamentals: All Metrics, Ratios and Statistics

IBEX TECHNOLOGIES INC

TSX-V:IBT (4/5/2024, 7:00:00 PM)

1.44

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)12-15
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.30M
Revenue(TTM)7.80M
Net Income(TTM)4.04M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9
Fwd PE N/A
P/S 4.53
P/FCF 34.47
P/OCF 15.87
P/B 2.47
P/tB 2.47
EV/EBITDA 14.11
EPS(TTM)0.16
EY11.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY2.9%
OCF(TTM)0.09
OCFY6.3%
SpS0.32
BVpS0.58
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 22.64%
ROE 28.25%
ROCE 9.74%
ROIC 6.83%
ROICexc 15.45%
ROICexgc 15.45%
OM 19.58%
PM (TTM) 51.82%
GM 71.29%
FCFM 13.13%
ROA(3y)14.54%
ROA(5y)7.95%
ROE(3y)18.48%
ROE(5y)9.94%
ROIC(3y)9.26%
ROIC(5y)N/A
ROICexc(3y)24.64%
ROICexc(5y)N/A
ROICexgc(3y)24.64%
ROICexgc(5y)N/A
ROCE(3y)13.2%
ROCE(5y)N/A
ROICexgc growth 3Y5.1%
ROICexgc growth 5YN/A
ROICexc growth 3Y5.1%
ROICexc growth 5YN/A
OM growth 3Y11.49%
OM growth 5YN/A
PM growth 3Y41.01%
PM growth 5YN/A
GM growth 3Y6.79%
GM growth 5Y12.72%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.6
Debt/EBITDA 0.69
Cap/Depr 254.79%
Cap/Sales 15.38%
Interest Coverage 250
Cash Conversion 111.33%
Profit Quality 25.34%
Current Ratio 5.08
Quick Ratio 4.97
Altman-Z 4.22
F-Score6
WACC7.68%
ROIC/WACC0.89
Cap/Depr(3y)113.33%
Cap/Depr(5y)77.81%
Cap/Sales(3y)6.8%
Cap/Sales(5y)4.77%
Profit Quality(3y)120.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)139.95%
EPS 3Y59.15%
EPS 5YN/A
EPS Q2Q%20.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y12.87%
Revenue growth 5Y9.64%
Sales Q2Q%17.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.47%
EBIT growth 3Y25.85%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.16%
FCF growth 3Y-0.7%
FCF growth 5Y47.39%
OCF growth 1Y42.74%
OCF growth 3Y17.98%
OCF growth 5Y59.75%

IBEX TECHNOLOGIES INC / IBT.CA FAQ

Can you provide the ChartMill fundamental rating for IBEX TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 6 / 10 to IBT.CA.


What is the valuation status of IBEX TECHNOLOGIES INC (IBT.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to IBEX TECHNOLOGIES INC (IBT.CA). This can be considered as Fairly Valued.


What is the profitability of IBT stock?

IBEX TECHNOLOGIES INC (IBT.CA) has a profitability rating of 8 / 10.


What is the valuation of IBEX TECHNOLOGIES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for IBEX TECHNOLOGIES INC (IBT.CA) is 9 and the Price/Book (PB) ratio is 2.47.